Intestinal Microbiota and Kidney Diseases

Ao Xie; Jie Sheng; Feng Zheng

doi:10.1007/s11655-017-2927-5

Your Location：

Home >

Browse articles >

Intestinal Microbiota and Kidney Diseases

Updated：2021-08-27

- Intestinal Microbiota and Kidney Diseases
- Chinese Journal of Integrative Medicine Vol. 24, Issue 6, Pages: 406-408(2018)
- Affiliations：
  
  Advanced Institute for Medical Science, The Second Hosptial, Dalian Medical University,Dalian,China
- Author bio：
- Funds：
- DOI：10.1007/s11655-017-2927-5
  CLC：
- Published：2018，
  
  Published Online：12 April 2018，
Scan for full text
Xie, A., Sheng, J. & Zheng, F. Intestinal Microbiota and Kidney Diseases., Chin. J. Integr. Med. 24, 406–408 (2018). https://doi.org/10.1007/s11655-017-2927-5

Ao Xie, Jie Sheng, Feng Zheng. Intestinal Microbiota and Kidney Diseases. [J]. Chinese Journal of Integrative Medicine 24(6):406-408(2018)
Xie, A., Sheng, J. & Zheng, F. Intestinal Microbiota and Kidney Diseases., Chin. J. Integr. Med. 24, 406–408 (2018). https://doi.org/10.1007/s11655-017-2927-5 DOI：

Ao Xie, Jie Sheng, Feng Zheng. Intestinal Microbiota and Kidney Diseases. [J]. Chinese Journal of Integrative Medicine 24(6):406-408(2018) DOI： 10.1007/s11655-017-2927-5.

摘要

Kidney diseases are common and the incidence rate is increasing. Gut microbiota is involved in metabolic and immune regulation of the host. Genetic

alimentary and environmental disease factors may change gut flora and increase opportunistic and pathogenic bacteria

contributing to immune or non-immune mediated kidney diseases including IgA nephropathy and diabetic nephropathy. Additionally

bacterial metabolites may be a source of uremic toxins. Thus

identification of diversity

composition

and metabolic and immunologic features of gut bacteria in chronic kidney diseases may help understand pathogenetic mechanism and develop therapy for diseases.

Abstract

Kidney diseases are common and the incidence rate is increasing. Gut microbiota is involved in metabolic and immune regulation of the host. Genetic

alimentary and environmental disease factors may change gut flora and increase opportunistic and pathogenic bacteria

contributing to immune or non-immune mediated kidney diseases including IgA nephropathy and diabetic nephropathy. Additionally

bacterial metabolites may be a source of uremic toxins. Thus

identification of diversity

composition

and metabolic and immunologic features of gut bacteria in chronic kidney diseases may help understand pathogenetic mechanism and develop therapy for diseases.

关键词

microbiotaIgA nephropathychronic kidney diseaseuremia

Keywords

microbiotaIgA nephropathychronic kidney diseaseuremia

references

Qin J, Li R, Raes J, Arumuqam M, Burqdorf KS, Manichanh C, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010;464:59–65.

Kiryluk K, Moldoveanu Z, Sanders JT, Eison TM, Suzuki H, Julian BA, et al. Aberrant glycosylation of IgA1 is inherited in both pediatric IgA nephropathy and Henoch-Schönlein purpura nephritis. Kidney Int 2011;80:79–87.

Kiryluk K, Li Y, Scolari F, Sanna-Cherchi S, Choi M, Verbitsky M, et al. Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens. Nat Genet 2014;46:1187–1196.

Ambruzs JM, Walker PD, Larsen CP. The histopathologic spectrum of kidney biopsies in patients with inflammatory bowel disease. Clin J Am Soc Nephrol 2014;9:265–270.

Rosanna C. The intestine-renal connection in IgA nephropathy. Nephrol Dial Transplant 2015;30:360–366.

Anders HJ, Andersen K, Stecher B. The intestinal microbiota, a leaky gut, and abnormal immunity in kidney disease. Kidney Int 2013;83:1010–1016.

Krishnamurthy VM, Wei G, Baird BC, Murtauqh M, Chonchol MB, Raphael KL, et al. High dietary fiber intake is associated with decreased inflammation and allcause mortality in patients with chronic kidney disease. Kidney Int 2012;81:300–306.

Ryu M, Kullkarni OP, Radomska E, Miosge N, Gross O, Anders HJ. Bacterial CpG-DNA accelerates Alport glomerulosclerosis by inducing an M1 macrophage phenotype and tumor necrosis factor-a-mediated podocyte loss. Kidney Int 2011;79:189–198.

Neal MD, Jia H, Eyer B, Good M, Guerriero CJ, Sodhi CP, et al. Discovery and validation of a new class of small molecule Tolllike receptor 4 (TLR-4) inhibitors. PLoS One 2013;8:e65779.

Vaziri ND, Wong J, Pahl M, Piceno YM, Yuan J, DeSantis TZ, et al. Chronic kidney disease alters the componsition of intestinal microbial flora. Kidney Int 2013;83:308–315.

Aronov PA, Luo FJ, Plummer NS, Quan Z, Holmes S, Hostetter TH, et al. Colonic contribution to uremic solutes. J Am Soc Nephrol 2011;22:1769–1776.

Lin CJ, Chen HH, Pan CF, Chuang CK, Wang TJ, Sun FJ, et al. p-Cresylsulfate and indoxyl sulfate level at different stages of chronic kidney disease. J Clin Lab Anal 2011;25:191–197.

Niwa T. Role of indoxyl sulfate in the progression of chronic kidney disease and cardiovascular disease: experimental and clinical effects of oral sorbent AST-120. Ther Apher Dial 2011;15:120–124.

Wang F, Zhang P, Jiang H, Cheng S. Gut bacterial translocation contributes to microinflammation in experimental uremia. Dig Dis Sci 2012;57:2856–2862.

FULL TEXT LINK

More>

Views

Downloads

CSCD

Alert me when the article has been cited

Submit

Tools

Publicity Resources

Management of chronic kidney disease in china calls for the implementation of expert patient program with traditional Chinese medical interventions

Effect of Sanqi Oral Liquid (三芪口服液) on the expressions of CD4+, CD8+ and CD68+ cells in 5/6 nephrectomized rats with chronic renal failure

Potential of renal pathology on refining syndrome typing of Chinese medicine in IgA nephropathy

Experimental study on effect of renal failure granule in treating uremia

Study on preventive effect of jiangu granule on osteoporosis in ovariectomized rats

Related Author

No data

Related Institution

Department of Nephrology, Guangdong Provincial Hospital of Chinese Medicine

Department of Urology, Guangdong Provincial Hospital of Traditional Chinese Medicine

Guangzhou University of Chinese Medicine

Pharmaceutical Manufacturing Section, Guangdong Provincial Hospital of Traditional Chinese Medicine

Epidemiological Teaching and Research Section, Guangdong Provincial Hospital of Traditional Chinese Medicine

Address：1 Caochang, xiyuan, Beijing, People's Republic of China Postal code：100091
Tel：010-62886827, 62877592 Fax：010-62874291
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备05067934号-1 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰